Have a personal or library account? Click to login
A review of in vitro methods to predict the clinical significance of red blood cell alloantibodies Cover

A review of in vitro methods to predict the clinical significance of red blood cell alloantibodies

Immunohematology
Volume 34 (2018): Issue 1 (March 2018)
By:
Paid access
|Oct 2019

References

  1. De Wees W. Editorial comment. Philadelphia Journal of Medical and Physical Sciences 1825:207.
    Search in Google ScholarBack to article
  2. Doubleday E. Case of uterine haemorrhage successfully treated by the operation of transfusion. Philadelphia Journal of Medical Physics 1825;54:380–6.
    Search in Google ScholarBack to article
  3. Chapman JF, Elliott C, Knowles SM, et al. Guidelines for compatibility procedures in blood transfusion laboratories: British Committee for Standards in Haematology. Transfus Med 2004;14:50–73.
    Search in Google ScholarBack to article
  4. AABB Standards Program Committee. Standards for immunohematology reference laboratories. 9th ed. Arlington, VA: AABB, 2016.
    Search in Google ScholarBack to article
  5. U.S. Food and Drug Administration. Transfusion associated fatalities 2010–2014. Available from www.fda.gov. Accessed May 2017
    Search in Google ScholarBack to article
  6. Bolton-Maggs PHB, Cohen H. Serious Hazards of Transfusion (SHOT) haemovigilance and progress in improving transfusion safety. Br J Haematol 2013;1:1–12.
    Search in Google ScholarBack to article
  7. Moncharmont P, Barday G, Py J-Y, et al. Acquired red blood cell alloantibodies in transfused patients of 80 years or over: a 2008–2013 national haemovigilance survey. Blood Transfus 2017;15:254–8.
    Search in Google ScholarBack to article
  8. Leger R. In vitro cellular assays and other approaches used to predict the clinical significance of red cell alloantibodies: a review. Immunohematology 2002;18:65–70.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.21307/immunohematology-2019-512" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.21307/immunohematology-2019-512</a></dgdoi:pub-id>
    Search in Google ScholarBack to article
  9. Daniels G, Poole J, De Silva M, et al. The clinical significance of blood group antibodies. Transfus Med 2002;12:287–95.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1046/j.1365-3148.2002.00399.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1365-3148.2002.00399.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">12383334</dgpm:pub-id>
    Search in Google ScholarBack to article
  10. Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007;21:58–71.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/j.tmrv.2006.08.003" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.tmrv.2006.08.003</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">17174221</dgpm:pub-id>
    Search in Google ScholarBack to article
  11. Whitaker BI, Strong DM, Gandhi MJ, Petrisli E. Hemovigilance and the Notify Library. Immunohematology 2017;33:159–64.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.21307/immunohematology-2019-023" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.21307/immunohematology-2019-023</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">34841819</dgpm:pub-id>
    Search in Google ScholarBack to article
  12. Garratty G. The James Blundell Award Lecture 2007: Do we really understand immune red cell destruction. Transfus Med 2008:18;321–34.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1365-3148.2008.00891.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1365-3148.2008.00891.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">19140815</dgpm:pub-id>
    Search in Google ScholarBack to article
  13. Zupanska B, Thompson E, Brojer E, Merry AH. Phagocytosis of erythrocytes sensitized with known amounts of IgG1 and IgG3 anti-Rh antibodies. Vox Sang 1987;53:96–101.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1159/000461705" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1159/000461705</a></dgdoi:pub-id>
    Search in Google ScholarBack to article
  14. Garratty G, Nance SJ. Correlation between in vivo hemolysis and the amount of red cell-bound IgG measured by flow cytometry. Transfusion 1990:30;617–21.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1046/j.1537-2995.1990.30790385519.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1537-2995.1990.30790385519.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">2402775</dgpm:pub-id>
    Search in Google ScholarBack to article
  15. Garratty G. Effect of cell-bound proteins on the in vivo survival of circulating blood cells. Gerontology 1991:37;68–94.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1159/000213252" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1159/000213252</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">2055500</dgpm:pub-id>
    Search in Google ScholarBack to article
  16. Hadley AG. A comparison of in vitro tests for predicting the severity of hemolytic disease of the fetus and newborn. Vox Sang 1998;74:375–83.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1423-0410.1998.tb05445.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1423-0410.1998.tb05445.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">9704470</dgpm:pub-id>
    Search in Google ScholarBack to article
  17. Hadley AG. The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh(D) antibodies. Clin Lab Haematol 1988;10:377–84.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1365-2257.1988.tb01184.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1365-2257.1988.tb01184.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">3150696</dgpm:pub-id>
    Search in Google ScholarBack to article
  18. Garratty G. Predicting the clinical significance of red cell antibodies with in vitro cellular assays. Transfus Med Rev 1990;4:297–312.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/S0887-7963(90)70272-6" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S0887-7963(90)70272-6</a></dgdoi:pub-id>
    Search in Google ScholarBack to article
  19. Nance S, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449–52.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1046/j.1537-2995.1987.27688071692.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1537-2995.1987.27688071692.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">3686653</dgpm:pub-id>
    Search in Google ScholarBack to article
  20. Schanfield M, Stevens JO, Bauman D. The detection of clinically significant erythrocyte alloantibodies using human mononuclear phagocyte assay. Transfusion 1981;21:571–6.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1046/j.1537-2995.1981.21582040822.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1537-2995.1981.21582040822.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">6794195</dgpm:pub-id>
    Search in Google ScholarBack to article
  21. Zupanska B, Brijer E, McIntosh J, et al. Correlation of monocyte monolayer assay results, number of erythrocyte-bound IgG molecules, and IgG subclass composition in the study of red cell alloantibodies other than D. Vox Sang 1990;58:276–80.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1423-0410.1990.tb04999.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1423-0410.1990.tb04999.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">2399692</dgpm:pub-id>
    Search in Google ScholarBack to article
  22. Mollison PL. Blood-group antibodies and red-cell destruction— II. Br Med J 1959:2:1123–30.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1136/bmj.2.5160.1123" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1136/bmj.2.5160.1123</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmcid">1990771</dgpm:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">14423434</dgpm:pub-id>
    Search in Google ScholarBack to article
  23. Postoway N, Nance S, O’Neill P, Garratty G. Comparison of a practical differential agglutination procedure to flow cytometry in following the survival of transfused red cells. Transfusion 1985;25:453.
    Search in Google ScholarBack to article
  24. Nance S, Scharberg EA, Thornton N, Yahalom V, Sareneva I, Lomas-Francis C. International rare donor panels: a review. Vox Sang 2016;110:209–18.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/vox.12357" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/vox.12357</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">26689301</dgpm:pub-id>
    Search in Google ScholarBack to article
DOI: https://doi.org/10.21307/immunohematology-2018-004 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 11 - 15
Published on: Oct 16, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
RBC alloantibodies,
clinical significance,
ISBT Academy Day
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2019 S.J. Nance, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous articleVolume 34 (2018): Issue 1 (March 2018)Next article